Erythromycin Lactobionate for Injection 1g (10vials/box)

• Dossier: Ctd
• Transport Package: Free
• Specification: 1g
• Trademark: Sinolead
• Origin: China
• Model NO.: Powder Injection

Product Description

 

Basic Info.

 

Generic Name	Erythromycin Lactobionate for Injection
Strength	1g
Packing	10 vials/box
Origin	China

Component:
Erythromycin Lactobionate

Character:

This product is white or quasi-white crystal or loose mass.

Indications:

1. This product is used as an alternative medicine for patients with penicillin allergy in the treatment of the following infections: acute tonsillitis, acute pharyngitis, and sinusitis caused by hemolytic streptococcus and streptococcus pneumoniae; Scarlet fever and cellulitis caused by hemolytic streptococcus; Diphtheria and diphtheria carriers; Gas gangrene, anthrax, tetanus; Actinomycosis; Syphilis; Listeriosis, etc. 2. Legionella disease. 3. Mycoplasma pneumonia. 4. Chlamydia pneumonia. 5. Other chlamydia, mycoplasma caused by genitourinary infection. 6. Chlamydia trachomatis conjunctivitis. Seven. Gonococcal infection. 8. Oral infection caused by anaerobic bacteria. 9. Campylobacter jejuni enteritis. 10. Whooping cough.

 

Usage and dosage:

Intravenous infusion: Adults 0.5 ~ 1.0g once, 2 ~ 3 times a day. The dosage of legionella disease should be increased to 3 ~ 4g a day, divided into 4 times. No more than 4g per day for adults. Children are divided into 2 to 3 times per day according to body weight 20 to 30mg/kg. For preparation of erythromycin lactobionate infusion, add 10ml of sterilized water for injection to 0.5g erythromycin lactobionate powder bottle or add 20ml to 1g erythromycin lactobionate powder bottle and shake vigorously until dissolved. Then add normal saline or other electrolyte solution dilution, slowly intravenous drip, pay attention to erythromycin concentration within 1% ~ 5%. After dissolution, it can also be diluted with a solution containing glucose, but because the glucose solution is acidic, it is necessary to add 1ml of 4% sodium bicarbonate to every 100ml solution.

Matters needing attention:

1. When hemolytic streptococcal infection is treated with this product, it should last at least 10 days to prevent the occurrence of acute rheumatic fever.

2. Patients with renal dysfunction generally do not need to reduce the dosage.

3. Liver function was followed up regularly during medication. The dose of erythromycin should be reduced appropriately in patients with liver disease and severe renal impairment.

4. Patients who are allergic or unable to tolerate one erythromycin preparation may also be allergic or unable to tolerate other erythromycin preparations.

5. Interference to diagnosis: Erythromycin can interfere with Higerty method fluorescence determination, making the urinary catecholamine determination value appear false increase. Serum alkaline phosphatase, bilirubin, alanine aminotransferase and aspartate aminotransferase may be increased.

6. Because the sensitivity of different bacteria to erythromycin is different to some extent, the drug sensitivity should be determined.